MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Limb myorhythmia treated with chemodenervation: A case report

    N. Saez Calveras, M. Bryarly, M. Salinas (Dallas, USA)

    Objective: To describe the case of a patient with limb myorhythmia successfully treated with bolutinum toxin injections. Background: Myorhythmia is a rare condition characterized by…
  • 2022 International Congress

    Novel Antipsychotics and Risk of Drug-Induced Movement Disorders and Tardive Syndromes

    G. Kannarkat, S. Caroff, J. Morley (Philadelphia, USA)

    Objective: To review evidence on the risk of drug-induced movement disorders (DIMDs) with newer antipsychotic (AP) drugs. Background: DIMDs, both acute/subacute “extrapyramidal symptoms” and chronic…
  • 2022 International Congress

    The frequency of glucocerebrosidase mutations in a subgroup of early-onset Parkinson’s disease patients in the Korean population

    J. Lee, J. Hwangbo (Yangsan, Republic of Korea)

    Objective: We investigated the frequency of GBA mutations in the Korean patients with early-onset Parkinson’s disease (PD). Background: Glucocerebrosidase (GBA) mutations are associated with increased…
  • 2022 International Congress

    Profiling the biochemical lysosomal activities in blood of patients with LRRK2 G2019S associated Parkinson’s disease

    K. Basharova, A. Bezrukova, I. Miliukhina, A. Timofeeva, E. Zakharova, S. Pchelina, T. Usenko (Gatchina, Russian Federation)

    Objective: To replicate the previous study of Alcalay and coauthors on estimation of lysosomal enzymes activities [1] with additional estimation of corresponding substrates in patients…
  • 2022 International Congress

    Central olfactory structure atrophy is linked to synucleinopathy conversion in idiopathic REM sleep behavior disorder

    KA. Woo, JY. Lee, H. Kim, YK. Kim (Seoul, Republic of Korea)

    Objective: We hypothesized that early structural changes in the brain olfactory relevant structures may help early identification of those at risk of future disease conversion…
  • 2022 International Congress

    A modified Delphi panel to establish a threshold of meaningful progression on MDS-UPDRS Part III

    D. Trundell, L. Barrett, R. Rogers, E. Davies, S. Zanigni, N. Pross, G. Pagano, T. Nikolcheva, S. Cano (Welwyn Garden City, United Kingdom)

    Objective: To establish a threshold for meaningful progression on MDS-UPDRS Part III in an early-stage Parkinson's disease (PD) population (Hoehn & Yahr [H&Y] Stage I–II)…
  • 2022 International Congress

    The distinctive functional connectivity of the cholinergic nucleus basalis of Meynert in Parkinson’s disease across different motor subtypes

    M. Nazmuddin, P. Zeidman, T. van Laar (Surabaya, Indonesia)

    Objective: We aim to compare the state of cortical-NBM functional connectivity across healthy control (HC), PIGD-predominant PD (PIGD-PD), and tremor-dominant PD (TD-PD). Additionally, the correlation…
  • 2022 International Congress

    Long-term outcome of adaptive DBS using LFP sensing technology

    K. Kimura, H. Kishida, N. Ueda, F. Tanaka (Yokohama, Japan)

    Objective: The aim of this study was to clarify the long-term outcome of Parkinson’s disease patients receiving STN-DBS with adaptive DBS setting. Background: It has…
  • 2022 International Congress

    Voluntary saccades slowness in parkinson disease and multiple system atrophy

    JY. Yoon, CY. Lee, HJ. Kim, SH. Kim (Seoul, Republic of Korea)

    Objective: This study aimed to explore and compare visually-guided and memory-guided saccades in PD and MSA. Background: Parkinson’s disease (PD) produced oculomotor alterations such as…
  • 2022 International Congress

    Coexistence of Parkinson’s Disease and Myasthenia Gravis: Disease Characteristics and Confusion

    Z. Mao, Q. Nie, Z. Li, Z. Xue (Wuhan, China)

    Objective: In order to alert clinicians to the possibility of the coexistence of the two diseases and optimize the management of both conditions. Background: Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 81
  • 82
  • 83
  • 84
  • 85
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley